- Investing Ideas
- South Korean Pharmaceuticals & Biotech High Return On Equity, Low Debt
South Korean Pharmaceuticals & Biotech High Return On Equity, Low Debt
Results
4
Stocks with a return on equity of over 30% and a debt to equity ratio below 1.
4 companies
SK Biopharmaceuticals
Market Cap: ₩6.9t
A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.
A326030
₩90,500.00
7D
4.7%
1Y
-0.5%
Oscotec
Market Cap: ₩1.5t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩38,850.00
7D
-1.4%
1Y
41.8%
DongKoo Bio & Pharma
Market Cap: ₩111.0b
Manufactures and sells pharmaceuticals in South Korea.
A006620
₩4,105.00
7D
3.5%
1Y
-25.4%
JW Shinyak
Market Cap: ₩100.5b
Engages in the research, development, production, and sale of medicines and medical supplies in South Korea.
A067290
₩1,798.00
7D
33.9%
1Y
11.2%